Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy

NCT00671060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Intrauterine Fetal Demise

Interventions

DRUG: Misoprostol
DRUG: Misoprostol

Sponsor

Gynuity Health Projects

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]